Valá
ek,1,2*
Klaus H. Nielsen,1
Fan Zhang,1
Christie A. Fekete,1 and
Alan G. Hinnebusch1*
Laboratory of Gene Regulation and Development, National Institute of Child Health and Human Development, Bethesda, Maryland,1 Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic2
Received 25 June 2004/ Accepted 27 July 2004
| ABSTRACT |
|---|
|
|
|---|
ternary complex (TC) to form the multifactor complex (MFC). We investigated the physiological importance of these interactions by mutating 16 segments spanning the NIP1-NTD. Mutations in multiple segments reduced the binding of eIF1 or eIF5 to the NIP1-NTD. Mutating a C-terminal segment of the NIP1-NTD increased utilization of UUG start codons (Sui phenotype) and was lethal in cells expressing eIF5-G31R that is hyperactive in stimulating GTP hydrolysis by the TC at AUG codons. Both effects of this NIP1 mutation were suppressed by eIF1 overexpression, as was the Sui phenotype conferred by eIF5-G31R. Mutations in two N-terminal segments of the NIP1-NTD suppressed the Sui phenotypes produced by the eIF1-D83G and eIF5-G31R mutations. From these and other findings, we propose that the NIP1-NTD coordinates an interaction between eIF1 and eIF5 that inhibits GTP hydrolysis at non-AUG codons. Two NIP1-NTD mutations were found to derepress GCN4 translation in a manner suppressed by overexpressing the TC, indicating that MFC formation stimulates TC recruitment to 40S ribosomes. Thus, the NIP1-NTD is required for efficient assembly of preinitiation complexes and also regulates the selection of AUG start codons in vivo. | INTRODUCTION |
|---|
|
|
|---|
) base paired with the AUG start codon in the P site of the ribosome. A large number of soluble eukaryotic translation initiation factors (eIFs) have been identified that stimulate the partial reactions of this process (reviewed in reference 12 and 13). A critical step early in the pathway is the binding of Met-
to the 40S ribosomal subunit in a ternary complex (TC) comprised of Met-
, GTP, and eIF2. The recruitment of TC to 40S subunits is promoted in vitro by eIF1, eIF1A, and the eIF3 complex. The 43S preinitiation complex thus formed interacts with mRNA in a manner stimulated by eIF4F (eIF4A-eIF4E-eIF4G), poly(A)-binding protein, and eIF3, and the 43S complex scans the mRNA until the Met-
base pairs with an AUG triplet. AUG recognition triggers GTP hydrolysis by eIF2 in a reaction stimulated by eIF5, and the eIF2-GDP and other eIFs are ejected from the ribosome. The eIF1, eIF1A, and eIF4G have been implicated in the scanning process in vitro (23, 24). In the final reaction, eIF5B bound to GTP promotes joining of the 60S subunit with the 40S-Met-
-mRNA complex to produce the 80S initiation complex (15, 25). To begin a new round of initiation, the ejected eIF2-GDP complex must be recycled to eIF2-GTP by the guanine nucleotide exchange factor eIF2B (13). From extensive biochemical analysis of the mammalian initiation factors, it was proposed that eIF3 binds to the 40S ribosome independently of other factors and promotes the recruitment of TC and mRNA in a manner stimulated by eIF1 and eIF1A (reviewed in references 12 and 13). There is also evidence, however, that eIF2 stimulates 40S-binding by eIF3 and that eIF3 enhances 40S binding of eIF1 and eIF1A (18). Furthermore, eIF1 and eIF1A cooperate with one another in binding to the 40S ribosome (17, 18) and in promoting TC recruitment (1, 18). In addition to these functional interactions, work in yeast has shown that eIF3, eIF5, and eIF1 are physically associated with one another and with the TC in a multifactor complex (MFC) that can exist free of ribosomes (2, 3, 26, 28, 29) (Fig. 1A). We have proposed that the physical contacts among the factors in the MFC, coupled with their intrinsic ribosome-binding activities, could underlie cooperative binding of the MFC components to the 40S subunit, enhancing assembly of the 43S complex. Formation of the MFC might also coordinate the functions of eIF1, eIF5, and TC in AUG recognition during scanning (7).
|
cells. This Gcd (for general control derepressed) phenotype was also identified for a mutation in eIF1A that appears to reduce 40S-binding by the TC (22).
Mutations that reduce the stringency of AUG selection in yeast have been isolated on the basis of restoring translation of a his4 allele lacking an AUG start codon by increasing initiation at an in-frame UUG triplet at the 5' end of the gene. Mutations with this Sui (for suppressor of initiation codon) phenotype were isolated in initiator tRNA, eIF5, eIF1, and all three subunits of eIF2 (reviewed in reference 7). Biochemical analysis of dominant Sui mutants in eIF2 subunits and eIF5 suggests that selection of UUG start codons can be enhanced by increasing the GTPase activity of eIF2, either directly by alterations in eIF2 or by stimulating the GTPase activating (GAP) function of eIF5. It was proposed that this biochemical defect increases the probability of inappropriate GTP hydrolysis and release of eIF2-GDP from Met-
base paired with a UUG triplet (14). The biochemical basis for the Sui- phenotypes of mutations in eIF1 is unknown. However, it was shown recently that mammalian eIF1 enables 48S complexes to reject mismatches between near-cognate start codons and Met-
independently of eIF5 (24). Interestingly, physical interaction between eIF1 and eIF4G, a subunit of the eIF4F complex, seems to enhance the accuracy of AUG selection during scanning (11). Thus far, no mutations in eIF3 have been described with a Sui phenotype, but we found recently that the prt1-1 mutation in eIF3b decreases selection of UUG as a start codon at HIS4, rendering initiation hyperaccurate (21).
The eIF5 C-terminal domain (eIF5-CTD) mediates many of the known interactions that stabilize the MFC, since it is capable of interacting simultaneously with eIF1, eIF2ß/SUI3, and the N-terminal domain of NIP1 (NIP1-NTD) (2-4). Thus, eIF5-CTD mediates an indirect contact between eIF2 and eIF3 in the MFC (Fig. 1A). The CTD of eIF3a/TIF32 mediates a second, direct contact with eIF2ß, and it also interacts with eIF1 (29). A multiple-alanine substitution in conserved residues of the eIF5-CTD, tif5-7A, leads to temperature-sensitive (Ts-) cell growth that is partially suppressed by overexpressing all three subunits of eIF2 and
, i.e., the macromolecules comprising the TC (3). The overproduction of TC (hc TC) also partially suppressed the slow-growth phenotype (Slg) conferred by overexpressing a dominant-negative TIF32 allele lacking the C-terminal binding domain for eIF2ß (hc TIF32-
6-His). Combining hc TIF32-
6-His with tif5-7A produces a synthetic growth defect and impairment of translation initiation (29) and leads to reduced binding of eIF2 to 40S subunits in vivo (21). These findings, together with the fact that tif5-7A impairs Met-
binding to 40S subunits in yeast extracts (4), support the notion that MFC formation enhances recruitment of TC to 40S subunits.
Surprisingly, the tif5-7A hc TIF32-
6-His double mutant does not exhibit the Gcd phenotype that would be expected for a defect in TC recruitment (29). It appears that tif5-7A additionally impairs postassembly functions of the MFC (4), most likely the rate of scanning between uORFs 1 and 4, and thus compensates for the delay in TC recruitment that results from destabilizing the MFC. The same mechanism probably explains the failure to induce GCN4 translation (Gcn phenotype) we observed recently in prt1-1 cells (21), despite the deleterious effect of this eIF3b mutation on 43S assembly in cell extracts (6, 26).
Considering that the NIP1-NTD interacts with eIF5-CTD, which in turn binds to eIF2ß, we set out to isolate substitution mutations in this segment of NIP1 that would disrupt the physical connection between eIF3 and the eIF5-CTD/eIF2 module of the MFC without impairing the postassembly functions of eIF5. Such mutations should decrease TC recruitment to 40S subunits and produce a Gcd phenotype that can be suppressed by hc TC. Because NIP1-NTD also interacts with eIF1, it seemed possible that other mutations in this segment would alter the stringency of AUG selection and produce a Sui phenotype or suppress known Sui mutations in eIF1 or eIF5. In this report we describe clustered alanine substitutions in NIP1-NTD that fulfill both of these predictions and provide in vivo evidence that the connections between eIF3 and other MFC components mediated by the NIP1-NTD enhance the assembly of 43S complexes and regulate the selection of AUG codons during scanning.
| MATERIALS AND METHODS |
|---|
|
|
|---|
ura3-52/ura3-52 trp1-63/trp1-63 leu2-3,112/leu2-3,112 his4-303[ATT]/his4-303[ATT] SUI1/sui1-1 NIP1/nip1
[pNIP1+ URA3]) that was created as follows. HLV01a (MATa ura3-52 trp1-63 leu2-3,112 his4-303[ATT]) and TD301-8D (MAT
leu2-3 leu2-112 ura3-52 his4-303[ATT] sui1-1) (provided by T. Donahue) were crossed, and the resulting hybrid was transformed with the nip1
::hisG-URA3-hisG cassette contained on pLV10 to delete one chromosomal copy of NIP1. Uracil auxotrophy was regained by growing the cells on 5-fluoro-orotic acid (5-FOA) plates, and the resulting strain was transformed with pNIP1+ (10) carrying wild-type (WT) NIP1 to produce HLV03. HLV01a was constructed by tetrad analysis of a cross involving H1515 (MATa ura3-52 leu2-3,112 trp1-63) and 76-3D (MAT
his4-303[ATT] ura3-52 leu2-3) (provided by T. Donahue). To produce HLV04-f, HLV04 was transformed with a fun12
::KanMX deletion cassette, and the deletion was verified by PCR analysis of chromosomal DNA. Strain HKN06 was created in two steps. First, strains H2881a and H2881
(21) were crossed, and the resulting hybrid was transformed with the nip1
::hisG-URA3-hisG to delete one chromosomal copy of NIP1. Uracil auxotrophy was regained on 5-FOA plates, and the resulting strain was then transformed with pNIP1+ to produce HKN05. The strain HKN06 was produced by tetrad dissection of HKN05.
|
|
|
YEpNIP1-Box1-His and YEpNIP1-Box2-His were constructed by insertion of a 1.1-kb HindIII-BbvCI fragment from YCpNIP1-Box1-His and YCpNIP1-Box2-His, respectively, into HindIII/BbvCI-cleaved YEpNIP1-His. YEpNIP1-Box6R-His was constructed by insertion of a 1.05-kB HindIII-NdeI fragment from YCpNIP1-Box6R into HindIII/NdeI-cleaved YEpNIP1-His. The 14 plasmids from YEpNIP1-Box3-His to YEpNIP1-Box16-His were constructed analogously by insertion of the 1.05-kb HindIII-NdeI fragments from YCpNIP1-Box3-His to YCpNIP1-Box16-His, respectively, into HindIII/NdeI-cleaved YEpNIP1-His.
YEpNIP1-N'-His-X is a derivative of YEpNIP1-N'-His that lacks XbaI in the multiple cloning site and was created to facilitate insertion of various NIP1-NTD mutations into the NIP1-N'-His construct. To produce YEpNIP1-N'-His-X, YEpNIP1-N'-His was cut with SalI, treated with Klenow Fragment, cut with SmaI, and then self-ligated. To create YEpNIP1-N'-Box2, -Box4, -Box6R, -Box12, -Box14, and -Box15-His, the 0.8-kb HindIII-XbaI fragments from YCpNIP1-Box2, -Box4, -Box6R, -Box12, -Box14, and -Box15-His, respectively, were inserted into HindIII/XbaI-cut YEpNIP1-N'-His-X.
pT7-NIP1-N' and the six related plasmids containing -Box2, -Box4, -Box6R, -Box12, -Box14, and -Box15 were constructed by insertion of the appropriate BamHI/HindIII-digested PCR product amplified from YEpNIP1-His, YEpNIP1-Box2, -Box4, -Box6R, -Box12, -Box14, and -Box15, respectively, into BamHI/HindIII-digested pT7-7 (27). The terminal restriction sites on the PCR fragments were introduced by the primers LVN-BHI-ATG (29) and LV22-HIII during PCR amplification.
To generate the NIP1 deletion plasmid pLV10, 0.16- and 0.87-kb fragments corresponding to the 5' and 3' ends of the NIP1 insert in pNIP1+ were amplified by PCR with pNIP1+ as a template and the primer pairs LV91-LV92 and LV101-LV102, respectively. The amplified 5' fragment was digested at its termini with HindIII and KpnI (both PCR incorporated) and subcloned between the HindIII and KpnI sites of a pUC18 derivative containing the hisG::URA3::hisG cassette to produce pLV09. Subsequently, the amplified 3' fragment was digested at its termini with SalI and SphI (both PCR incorporated) and subcloned between the SalI and SphI sites of pLV09 to produce pLV10. When digested with SacI and SphI, pLV10 yields a 4.9-kb fragment that can be used in yeast transformations to delete chromosomal NIP1.
To produce YEpTIF5-U and YEpTIF5-7A-U, we first digested YEpTIF5+SUI1 and YEpTIF5-7A+SUI1 (29) with HindIII and NaeI to remove an 827-bp fragment containing SUI1. The 5' overhangs of the remaining DNA were filled in with T4 DNA polymerase and self-ligated.YEpSUI1-U was created by excision of an
1.4-kb TIF5 fragment from YEpTIF5+SUI1 (29) by digestion with SalI and NruI, followed by end-filling with T4 DNA polymerase and self-ligation. To produce YCpTIF5-G31R-U, pKA235 (3) was cut with KpnI and NruI, and the resulting
1.3-kb fragment bearing nearly the entire TIF5 ORF was replaced with a KpnI-NruI fragment from p2187 (14) carrying TIF5-G31R.
To construct pRSSUI3-S264Y-U, plasmid p6-4 (provided by T. Dever) carrying WT SUI3 on a low-copy-number URA3 plasmid was cut with BglII and AgeI, and the resulting 261-bp fragment bearing the C terminus of SUI3 was replaced with a BglII-AgeI fragment from pBE66 (14) carrying SUI3-S264Y. To produce YCpTIF5-G31R-W, YCpTIF5-G31R-U was cut with SalI and EcoRI, and the resulting
2.2-kb fragment bearing TIF5-G31R was ligated with SalI/EcoRI-digested YCplac22. To generate YCpSUI3-S264Y-W, pRSSUI3-S264Y-U was digested with BamHI and SalI and the resulting
1.9-bp fragment bearing SUI3-S264Y was inserted into BamHI/SalI-cut YCplac22.
Biochemical techniques. Glutathione S-transferase (GST) pull-down experiments with bacterially expressed GST fusions and in vitro-synthesized 35S-labeled NIP1-NTD polypeptides, Ni2+ chelation chromatography of eIF3 complexes containing His-tagged proteins from yeast whole-cell extracts (WCEs), and Western blot analysis were all conducted as described previously (29). Formaldehyde cross-linking and fractionation of extracts by sedimentation through sucrose gradients were carried out according to (21). Measurements of ß-galactosidase in WCEs were conducted according to (19).
| RESULTS |
|---|
|
|
|---|
To examine this possibility, we individually replaced each of the 16 boxes of the NIP1-NTD with a string of ten alanine residues in the fully functional NIP1-His allele, which is tagged at the C terminus with eight histidine residues to facilitate affinity purification of the mutant proteins (29). In addition, the conserved Glu-rich stretch in Box6 (residues 51 to 59) was substituted with a stretch of nine arginine residues to convert it from a highly acidic to a highly basic segment (Box6R). The resulting NIP1-His alleles were introduced on single-copy (sc) or high-copy-number (hc) plasmids into a yeast strain deleted for chromosomal NIP1 by plasmid shuffling and subjected to phenotypic analysis. NIP1-His on the hc plasmid (hc NIP1-His) gives a level of His8-NIP1 expression that is
2-fold higher than that conferred by sc NIP1-His (data not shown). This modest overexpression allowed us to achieve essentially WT expression of the NIP1-Box6R-His and NIP1-Box1-His products which appear to be unstable. As discussed below, overexpression of other mutant NIP1 proteins exacerbated their phenotypes. Because NIP1 interacts independently with TIF32 and PRT1, overexpressing NIP1 leads to the formation of two defective subcomplexes: one containing NIP1, PRT1, TIF34, and TIF35 and the other containing TIF32 and NIP1 (29). Thus, the phenotypes conferred by certain NIP1 mutants were exacerbated by overexpression probably because the deleterious effects of the mutations were compounded by a reduction in the level of intact eIF3.
Only the Box1 and Box6R mutations were lethal on sc plasmids, but this lethality was suppressed when the mutant alleles were introduced on hc plasmids to compensate for the instability of the encoded proteins. The resulting hc Box6R mutant displayed a Slg phenotype at 16 and 30°C but grew like WT at 37°C, whereas the hc Box1 strain grew like WT at all temperatures. The Box12, Box14, and Box15 alleles conferred Slg and temperature-sensitive (Ts) phenotypes when present on sc or hc plasmids (Fig. 1D and data not shown). Western analysis showed that the products of these last three alleles were expressed at essentially WT levels from sc plasmids (data not shown). Thus, it appears that residues in boxes 12, 14, and 15 are important for an essential function of the NIP1-NTD and that replacement of the negatively charged residues in Box6 with arginines is highly deleterious to cell growth. All of the other NIP1-His mutations conferred WT growth at all temperatures on sc or hc plasmids (summarized in Fig. 1C, SUI1 row).
The D83G mutation in eIF1 encoded by the sui1-1 allele produces a Slg- phenotype at 30°C (30) and, as shown below, greatly reduces the steady-state level of eIF1 (Fig. 2D). If any of the NIP1-NTD mutations impair the association of eIF1 with eIF3 in vivo, they might be expected to exacerbate the Slg phenotype of sui1-1. To test this possibility, we introduced the mutant alleles into a sui1-1 nip1
strain by plasmid shuffling and determined the growth phenotypes of the resulting double mutants. (We examined only the hc NIP1-His alleles because we found that WT His8-NIP1 must be expressed from a hc plasmid to match the level of native NIP1 expressed from the chromosome in the sui1-1 strain.) All four NIP1-His mutations that conferred Slg phenotypes in the SUI1 strain (Box6R, Box12, Box14, and Box15) were synthetically lethal with sui1-1 (summarized in Fig. 1C, sui1-1 row). This interaction was specific since none of the NIP1 mutations were synthetically lethal with a deletion of FUN12 (encoding eIF5B) when introduced by plasmid shuffling into a fun12
nip1
strain (data not shown). Interestingly, five other NIP1-His alleles that produced no growth defects in the SUI1 strain (Box7, Box8, Box9, Box13, and Box16) also were synthetically lethal with sui1-1 (Fig. 1C). As shown in Fig. 2A (SD+His panel), all of the remaining mutations except Box5 exacerbated the Slg phenotype of sui1-1 (summarized in Fig. 1C). Importantly, Western analysis of WCEs showed that neither Box2 nor Box4, analyzed in depth below, exacerbated the instability of the sui1-1 product (Fig. 2D). These results are consistent with the idea that the NIP1-NTD promotes one or more functions of eIF1 in translation initiation that is impaired by sui1-1.
|
It was of interest to determine whether the Box2 or Box4 mutations would also suppress the Sui phenotypes conferred by mutations in a subunit of eIF2 or in the GAP eIF5 (7). The dominant Sui allele SUI3-S264Y, encoding a mutant form of eIF2ß, was shown to increase the GTPase activity of the TC independently of eIF5. The dominant Sui allele SUI5 (now called TIF5-G31R) encodes a mutant form of eIF5 displaying elevated GAP function (14). As expected, introducing SUI3-S264Y on a low-copy-number (lc) plasmid, or TIF5-G31R on an sc plasmid, into a his4-303 hc NIP1+-His strain suppressed the His phenotype of his4-303, confirming the dominant Sui phenotypes of these alleles (Fig. 2B, lanes 1 to 3). The dominant His+/Sui phenotypes conferred by SUI3-S264Y and TIF5-G31R were unaffected by replacement of hc NIP1-His with hc NIP1-Box2-His or hc NIP1-Box4-His (Fig. 2B, lanes 7 to 9, and data not shown). Thus, the Ssu phenotypes of the Box2 and Box4 mutations appear to be specific for sui1-1 However, it is remarkable that hc NIP1-Box6R-His completely suppressed the His+/Sui phenotypes conferred by SUI3-S264Y and TIF5-G31R (Fig. 2B, cf. lanes 2 and 3 and lanes 5 and 6). This last finding provides additional evidence that the NIP1-NTD is involved in AUG selection.
One way to account for the Ssu phenotype conferred by hc Box6R would be to propose that this mutation decreases the GAP function of eIF5, compensating for the elevated GTPase activity of eIF2 conferred by SUI3-S264Y or TIF5-G31R. Consistent with this idea, we found that the Slg phenotype of the hc Box6R mutant is partly suppressed by overexpression of eIF5 but not by overexpression of eIF5-7A (encoded by tif5-7A), from hc plasmids (Fig. 2C). Because the tif5-7A mutation weakens association of eIF5 with NIP1, eIF2ß, and eIF1 (2, 3), it appears that the overexpressed eIF5 must be capable of interactions with other MFC components to suppress the Slg phenotype conferred by hc Box6R. Thus, we propose that Box6R disrupts the interaction of eIF5 with one or more components of the MFC in a manner that reduces eIF5 GAP function, and this defect can be corrected through mass action by increasing the eIF5 concentration in the cell.
A decrease in eIF5 GAP function could also account for suppression of the Sui- phenotype of sui1-1 by the Box2 and Box4 mutations if we assume that sui1-1 leads to increased GTP hydrolysis at UUG triplets. In accordance with this hypothesis, we found that plasmid-borne TIF5-G31R is synthetically lethal with sui1-1 and that lc SUI3-S264Y partially exacerbates the Slg phenotype of sui1-1 (data not shown). Given that sui1-1 is recessive for the Sui phenotype, we propose that one function of eIF1 is to inhibit eIF5-stimulated GTP hydrolysis by the TC positioned at non-AUG triplets. Supporting this idea, we observed that the strong Sui phenotype of TIF5-G31R is suppressed by overexpressing eIF1 from an hc plasmid (Fig. 3A). This last result suggests that eIF1-eIF5 association contributes to the inhibition of eIF5 GAP function by eIF1.
|
2-fold, but it produced much larger proportional increases for the corresponding UUG and AUU fusions (Fig. 3C). Consequently, hc Box12 led to 3.2- and 5-fold greater utilization of UUG or AUU, respectively, than in the WT strain, increasing initiation from these triplets to levels of
20 and
5%, respectively, of that seen for AUG. By comparison, sui1-1 increased UUG or AUU utilization by 9.8- and 5-fold, respectively (Fig. 3D). Thus, hc Box12 is comparable to sui1-1 in boosting initiation at AUU triplets but is somewhat less effective than suil-1 for UUG triplets. Interestingly, the Sui and Slg phenotypes of the Box12 mutation were intensified by overexpression of WT eIF5 but not by overproduction of the mutant eIF5-7A protein (Fig. 3B, cf. rows 7 to 9). Remarkably, exacerbation of the Sui phenotype of the Box12 mutation produced by overexpressing eIF5 was completely reversed by co-overexpressing eIF1 from an hc SUI1 plasmid (Fig. 3B, cf. columns 8 and 11). (Note that overexpressing eIF1 intensified the growth defect of the Box12 mutant overexpressing eIF5; however, this reduction in growth rate was not sufficient to explain the complete loss of growth on the medium without histidine where the Sui phenotype is scored.) A similar comparison indicates that overexpressing eIF1 suppresses the Sui phenotype of Box12 in cells expressing native levels of eIF5 (Fig. 3B, cf. columns 7 and 10). To account for these findings, we suggest that the increased utilization of UUG produced by Box12 results from a defect in eIF1-eIF5 interaction, with attendant activation of eIF5 GAP function, and this defect can be reversed through mass action by overexpressing eIF1. Further support for this hypothesis came from our finding that Box12 is synthetically lethal with the hyperactive TIF5-G31R allele and that this synthetic interaction is also suppressed by overexpressing eIF1 (data not shown). Thus, it appears that Box12 increases the level of GTP hydrolysis at UUG codons to an extent that is intolerable in combination with the activated eIF5-G31R protein and that these defects can be fully corrected by increasing the cellular concentration of eIF1. These genetic findings support the idea that eIF1 negatively regulates eIF5 GAP function at non-AUG codons. Below, we offer an explanation for the fact that overexpressing eIF5 exacerbates the Sui phenotype of the Box12 mutation.
NIP1 mutations impair physical interactions of eIF5 and eIF1 with the NIP1-NTD in vitro and in vivo. The genetic results presented thus far suggest that mutations in Box2, Box4, and Box6R in the N-terminal portion of the NIP1-NTD reduce eIF5-stimulated GTP hydrolysis by the ternary complex and thereby suppress the Sui phenotypes conferred by sui1-1 or TIF5-G31R. In contrast, the Box12 mutation in the C-terminal portion of the NIP1-NTD appears to increase eIF5 GAP function, being lethal in the presence of hyperactive eIF5-G31R and producing a Sui phenotype on its own (summarized in Fig. 1B and below in Fig. 7). Our findings that sui1-1 is lethal with TIF5-G31R and that overexpression of eIF1 suppresses the Sui phenotype of TIF5-G31R imply that defects in eIF1 can increase eIF5 GAP function through a defective eIF5-eIF1 interaction. Accordingly, the NIP1-NTD mutations could influence eIF5 activity by altering the interaction of NIP1 with eIF5, eIF1, or both factors. To test this possibility, we examined the effects of Box2 and the four NIP1-NTD mutations that confer Slg phenotypes on in vitro binding of 35S-labeled NIP1-NTD to GST-eIF5 or GST-eIF1 fusions produced in Escherichia coli.
|
10% of that seen for WT NIP1-NTD. A similar result was obtained for Box4, although the binding defect was less severe. In contrast, Box12 and Box6R had greater effects on NIP1-NTD binding to GST-eIF1 versus GST-eIF5, whereas Box14 and Box15 reduced binding to GST-eIF1 and GST-eIF5 by similar amounts (Fig. 4A). The Box6R mutation showed the strongest overall binding defects among the six NIP1 mutations analyzed, in accordance with the fact that it produced the strongest Slg defect at 30°C in vivo (Fig. 1D).
|
We could not conduct similar Ni2+ binding assays on Box6R or the other two NIP1 mutations with interesting phenotypes (Box12 and Box15) because they either destabilized the His8-NIP1-NTD or prevented its binding to nickel resin. However, we succeeded in analyzing the effects of the alanine substitutions in Box6 (the Box6 mutation). Unlike Box6R or Box2, the Box6 mutation does not produce an Ssu phenotype, but it resembles Box2 in reducing the binding of NIP1-NTD to eIF5 and eIF2 in WCEs, with little effect on the interaction of NIP1-NTD with eIF1 (Fig. 4D). It also produces a modest, but reproducible, reduction in the amount of eIF5 and eIF2 associated with the eIF3/eIF1 subcomplex of the MFC in vivo (Fig. 4E). The effects of Box6 on these interactions are less pronounced than observed for Box2 (cf. Fig. 4B and C to Fig. 4D and E), a finding consistent with the absence of an Ssu phenotype for the Box6 mutant. However, these results provide biochemical evidence that Box6 residues contribute to the association of eIF5 with the NIP1-NTD in vivo. Additional support for this conclusion is provided in the next section.
NIP1-NTD mutations impair 43S/48S preinitiation complex assembly in vivo. We proposed above that the Box2 mutation suppresses the Sui phenotype of sui1-1 by reducing eIF5-stimulated GTP hydrolysis by the ternary complex. The biochemical results just described show that Box2 weakens the association of eIF5 with both the isolated NIP1-NTD and the eIF3/eIF1 subcomplex of the MFC in cell extracts. Accordingly, we sought to determine whether Box2 reduces the association of eIF5 with 43S preinitiation complexes in sui1-1 cells. To answer this question, we used a recently devised technique in which living yeast cells are treated with formaldehyde to cross-link native preinitiation complexes in vivo. The composition of these complexes is then examined by Western analysis after resolving the WCEs by sedimentation through sucrose density gradients (21). As shown in Fig. 5A, we observed the expected cosedimentation of a proportion of eIF2, -3, -5, and -1A with the 40S subunit in the sui1-1 strain, a behavior indicative of 43S or 48S preinitiation complexes. We failed to observe 40S binding of the sui1-1 product itself despite its presence in the WCEs (Fig. 5A and B, input lane), whereas 40S-binding of WT eIF1 in SUI1 strains is detectable by this technique (Fig. 5C). Interestingly, the Box2 mutation led to a marked depletion of eIF5 in the 40S fraction from sui1-1 cells (Fig. 5A and B). We did not observe this defect in SUI1 cells expressing the NIP1-Box2-His product (data not shown), indicating that loss of eIF5 from the 40S ribosomes occurs only when Box2 is combined with sui1-1. Presumably, the defect in association of eIF5 with the NIP1-NTD conferred by Box2 is compensated in SUI1+ cells by the direct interactions of eIF5 with eIF1 and eIF2 (2), thus permitting efficient recruitment of eIF5 to 40S subunits. These findings support the idea that the Ssu- phenotype of Box2 in sui1-1 cells arises from a reduction in eIF5 GAP function resulting from impaired binding of eIF5 to preinitiation complexes. The fact that eIF5 association with 43S-48S complexes is not reduced by Box2 in otherwise WT cells is consistent with the fact that Box2 does not suppress the Sui phenotype of TIF5-G31R.
|
20% of WT levels (cf. Fig. 5C and D). Note that the total amounts of eIF5 and eIF2 are reduced in the Box6R extract compared to WT (cf. "In" lanes in Fig. 5C and D). Hence, we cannot eliminate the possibility that the impaired binding of eIF5 and eIF2 to 40S subunits produced by Box6R at least partly reflects the decreased amounts of these factors in the extract rather than a decrease in their binding to 40S subunits. However, quantification of the input lanes shows that the decrease in eIF5 and eIF2 levels is not sufficient to explain their reduced association with 40S subunits in Box6R cells.
The NIP1-NTD is required for efficient recruitment of the ternary complex to 40S ribosomes and GCN4 translational control.
The ß-subunit of eIF2 makes an indirect contact with the NIP1-NTD that is bridged by eIF5-CTD (Fig. 1A). Mutations in the NIP1-NTD that impair its interaction with eIF5 may weaken the association of TC with the MFC and reduce the rate of TC binding to 40S subunits in vivo. If diminished recruitment of TC is the primary defect resulting from such mutations, they should constitutively derepress GCN4 translation in cells lacking the kinase GCN2 (Gcd phenotype). Because gcn2
mutants cannot induce GCN4 and amino acid biosynthetic enzymes under its control, they fail to grow on medium containing the inhibitor of histidine biosynthesis, 3-aminotriazole (3-AT). Interestingly, the hc Box6R, Box14, and Box15 mutations all permit robust growth of a gcn2
strain on medium containing 30 mM 3-AT (Gcd phenotypes), even though they confer Slg phenotypes on medium lacking 3-AT (Fig. 6A, lanes 7, 9, and 11, and data not shown). We quantified the Gcd phenotypes of the hc Box6R and hc Box15 mutants by assaying expression of a GCN4-lacZ reporter containing all four uORFs in the mRNA leader (p180). As expected, addition of 3-AT to a GCN2 NIP1 strain produced
9-fold induction of GCN4-lacZ expression, whereas the gcn2
NIP1 strain showed constitutively low GCN4-lacZ expression (Fig. 6B, lanes 1 to 4). Importantly, the hc Box6R and hc Box15 mutations led to
5- and
6-fold derepression of GCN4-lacZ expression in the gcn2
background (Fig. 6B, lanes 4 to 7). A control construct lacking all four uORFs (for which translational control is destroyed) showed similar high levels of GCN4-lacZ expression in all of the strains, indicating that mRNA stability was unaffected by the NIP1 mutations (data not shown). Thus, the NIP1 mutations led to the derepression of GCN4 translation independently of eIF2
phosphorylation by GCN2.
|
6 allele, lacking the C-terminal binding domain for eIF2ß in the eIF3a/TIF32 subunit (29), exacerbated the Slg and Gcd phenotypes of the Box15 mutation (Fig. 6C and data not shown). Thus, combining mutations in the NIP1-NTD and TIF32-CTD that weaken the independent contacts between eIF3 and eIF2 in the MFC appears to produce an additive reduction in TC binding to 40S subunits in vivo. Consistent with this interpretation, we found that hc Box15 reduces the binding of eIF2 to 40S subunits in cross-linked cells (Fig. 5E).
In contrast to our findings on hc Box15, the Slg phenotype of hc Box6R was not suppressed by hc TC and was only slightly exacerbated by TIF32-
6 (Fig. 6C). Based on the Ssu- phenotype of hc Box6R and the suppression of its Slg phenotype by hc TIF5, we concluded above that Box6R reduces eIF5 GAP activity. Thus, all of our genetic findings on hc Box6R can be explained by proposing that the rate-limiting defect in this mutant is the impairment of eIF5 GAP function resulting from a defective interaction of the NIP1-NTD with eIF5 (producing the Slg and Ssu- phenotypes) and that a reduction in TC recruitment is a secondary consequence of this mutation that is responsible for its Gcd phenotype.
| DISCUSSION |
|---|
|
|
|---|
Evidence that NIP1-NTD mutations disrupt AUG start codon selection by eIF1 and eIF5.
The sui1-1 mutation in eIF1 increases the utilization of UUG start codons at his4-303 (Sui phenotype) (30), and we discovered that sui1-1 is synthetically lethal with TIF5-G31R, encoding a hyperactive form of eIF5 (14). These phenotypes are consistent with the idea that sui1-1 leads to an elevated level of eIF5-stimulated GTP hydrolysis by the TC that becomes lethal in cells expressing eIF5-G31R. The sui1-1 allele is recessive for its Sui phenotype and the encoded eIF1-D83G protein is present at low levels in WCEs and in 43-48S preinitiation complexes (Fig. 2D and 5A). Hence, we propose that eIF1 normally functions to inhibit eIF5 GAP function at non-AUG codons and that this inhibitory activity is diminished in sui1-1 cells to permit increased utilization of UUG as start codon (see model in Fig. 8A and B). This proposal is consistent with the fact that the loss-of-function tif5-G62S (ssu2-1) mutation in eIF5 was isolated as a suppressor of sui1-1 (7). We provided additional support for this model by showing that overexpression of eIF1 suppresses the Sui phenotype of TIF5-G31R (Fig. 3A). This last finding suggests that eIF1 negatively regulates eIF5 GAP function at non-AUG triplets through a direct interaction between the two proteins, a finding consistent with the fact that eIF1 binds specifically to eIF5 in vitro (2). Interestingly, we found recently that eIF1 overexpression also suppresses the Sui phenotype of SUI3-S264Y (L. Valá
ek and A. G. Hinnebusch, unpublished observations), whose product exhibits high intrinsic GTPase activity in vitro. Thus, there is now considerable genetic evidence that eIF1 functions to inhibit GTP hydrolysis by the TC during scanning in the absence of perfect base pairing between Met-tRNAiMet and AUG in the P site.
|
with non-AUG triplets in the P site. In this way, eIF1 increases the processivity of scanning Y3S complexes and facilitates AUG selection. This activity is not incompatible with the regulatory function for eIF1 postulated in Fig. 8A. Base pairing between Met-
and AUG may trigger a conformational change in the 40S subunit or in eIF1 that stabilizes Met-
binding in the P site and at the same time disables the inhibitory effect of eIF1 on eIF5 GAP activity. Indeed, high-resolution mapping of the binding site for mammalian eIF1 on the 40S ribosome places it in the vicinity of the P site (16). To accommodate this last finding with current models for binding of eIF3 to the solvent side of the 40S ribosome, we suggested previously that interaction of eIF1 with the NIP1-NTD occurs only during recruitment of eIF1 to the 40S subunit and that eIF1 is subsequently transferred to its location near the P site while maintaining interaction with eIF5 (28). This configuration is depicted in the models in Fig. 8 presented to account for the effects of the Box2, Box6R, and Box12 mutations in NIP1 on AUG selection. The first genetic evidence implicating NIP1-NTD in AUG recognition came from our finding that the Box2 and Box4 mutations partially suppressed the Sui phenotype of sui1-1 (Ssu phenotype) (Fig. 2A). We also found that sui1-1 reduces the amount of eIF1 associated with the 48S complex, which should lead to increased GTP hydrolysis at non-AUG codons (Fig. 8B). Hence, we propose that the Box2 mutation partially compensates for this defect by disrupting a contact between eIF5 and the NIP1-NTD, leading to partial dissociation of eIF5 from preinitiation complexes in sui1-1 cells. This would decrease the efficiency of eIF5 GAP function and lower the rate of GTP hydrolysis by the TC at non-AUG codons, offsetting the increased rate of GTP hydrolysis produced by sui1-1 (Fig. 8C). Supporting this model, the Box2 mutation preferentially reduced association of the NIP1-NTD with eIF5 versus eIF1 in binding assays with recombinant proteins (Fig. 4A), and it had the same effect in yeast extracts for both the NIP1-NTD and full-length NIP1 (Fig. 4B and C). Furthermore, the Box2 mutation reduced binding of eIF5 to 40S subunits in cross-linked sui1-1 cells (Fig. 5). In contrast, in SUI1+ cells Box2 had no effect on association of eIF5 with preinitiation complexes in cross-linked cells, explaining why Box2 does not suppress the Sui phenotype of TIF5-G31R. The additive effect of sui1-1 and the Box2 mutation in reducing the amount of eIF5 associated with 43S-48S complexes implies that the eIF1-eIF5 interaction promotes eIF5 binding to 40S subunits. Thus, we propose that eIF1 is required for efficient eIF5 GAP function at AUG codons through its stimulatory effect on 40S binding of eIF5, while at the same time inhibiting eIF5 activity at non-AUG triplets. The mechanism just described for the Box2 mutation may also account for the Ssu- phenotype of the Box4 mutation, since the latter also selectively impairs interaction of the NIP1-NTD with eIF5 (Fig. 4A and data not shown).
The Box6R mutation suppressed the Sui phenotypes of the TIF5-G31R and SUI3-S264Y mutations (Fig. 2C), both of which increase GTP hydrolysis by the TC in vitro (14). According to our model, the G31R substitution in eIF5 activates GAP function to the point where it overcomes the inhibitory effect of eIF1 and permits elevated GTP hydrolysis at non-AUG codons (Fig. 8E). We propose that by weakening the interaction of eIF5 with the NIP1-NTD, Box6R would reduce the GAP function of eIF5 enough to suppress the elevated GTP hydrolysis at UUG codons produced by TIF5-G31R and SUI3-S264Y (Fig. 8F). (This explanation assumes that the GTPase activity of eIF2 harboring the SUI3-S264Y mutation is still stimulated by eIF5.) Supporting this model, the Slg phenotype of the Box6R mutation was partially suppressed by overexpressing eIF5 but not eIF5-7A (Fig. 2C). In addition, we found that Box6R led to a strong reduction in binding of NIP1-NTD to eIF5 in vitro (Fig. 4A). In vivo, it selectively reduced the binding of eIF5 and eIF2 to the overexpressed NIP1-NTD fragment and also impaired the association of eIF5 and eIF2 with eIF1 and the eIF3 complex (Fig. 4D and E). Finally, Box6R decreased the binding of eIF5, but not eIF1, to 40S subunits in cross-linked yeast cells (Fig. 5D), thus providing direct biochemical support for the model in Fig. 8F. We predict that the Box6R mutation would also suppress the Sui phenotype of sui1-1 and reduce the association of eIF5 with 40S subunits in sui1-1 cells, as observed for Box2; however, the lethality of Box6R in sui1-1 cells prevented us from testing this prediction.
The Box12 mutation produced a Sui phenotype (Fig. 3B and C), comparable to that given by lc SUI3-S264Y in SUI3+ cells (Fig. 2B). In addition, Box12 was synthetically lethal with the activated Sui allele TIF5-G31R. In both respects, Box12 qualitatively resembles sui1-1. Hence, we propose that Box12 leads to increased GTP hydrolysis by the TC at UUG triplets (Fig. 8D). This defect is intensified and becomes lethal when combined with the activating G31R mutation in eIF5. It is intriguing that the Sui phenotype of Box12 was exacerbated by overexpressing eIF5, but not eIF5-7A, and was suppressed by overexpressing eIF1. In addition, the effect of overexpressing eIF5 on the Sui phenotype of Box12 was overcome by co-overexpressing eIF1 (Fig. 3B). The simplest way to explain the suppression of the Box12 Sui phenotype by hc eIF1 is to propose that Box12 weakens the ability of eIF1 to interact with eIF5 in the manner required to inhibit eIF5 activity at non-AUG codons. Increasing the concentration of eIF1 would restore the correct interaction between eIF1 and eIF5 by mass action and reinstate the stringent regulation of eIF5 GAP function. Strongly supporting this interpretation, we found that overexpression of eIF1 eliminated the synthetic lethality produced by combining Box12 with TIF5-G31R.
To explain why overexpressing eIF5 exacerbates the Sui phenotype of the Box12 mutation (Fig. 3B), we suggest that excess eIF5 titrates a fraction of eIF1 from the MFC and sequesters it in inactive subcomplexes. This would stimulate GTP hydrolysis at non-AUG codons by reducing the inhibitory effect of eIF1 on eIF5, intensifying the Sui phenotype of the Box12 mutation. Co-overexpressing eIF1 with eIF5 would restore WT levels of eIF1 in the MFC. Because overexpressing eIF5 does not produce a Sui phenotype in WT cells (Fig. 3A), its ability to titrate eIF1 from the MFC would depend on a weakened interaction between eIF1 and the NIP1-NTD containing the Box12 mutation. Indeed, we found that Box12 impaired binding of eIF1 to the NIP1-NTD in vitro (Fig. 4A). It should be noted that we did not detect a reduction in eIF1 association with 40S subunits in cross-linked Box12 mutant cells (data not shown). Thus, it appears that Box12 alters the interaction of eIF1 with eIF5 on the 40S ribosome without diminishing eIF1 recruitment. We suggest that by increasing the residence time of eIF1 on the 40S subunit by overexpressing this factor we restored the eIF5-eIF1 interaction required for stringent regulation of eIF5 GAP function in Box12 mutant cells.
Evidence that mutations in the NIP1-NTD decrease the recruitment of TC to 40S ribosomes. The Box6R and Box15 mutations produced Gcd phenotypes in cells lacking protein kinase